Specialist in spijsvertering sinds 2008

Specialist in spijsvertering sinds 2008

Al sinds 2008 ontwikkelen en produceren wij voedingssupplementen. Onze producten worden met veel zorg en aandacht speciaal ontwikkeld door onze eigen diëtisten. Voor de samenstelling van onze producten gebruiken wij enkel noodzakelijke ingredienten, hierdoor zijn onze producten puur, vrij van gluten en soja en van hoge kwaliteit. Dit maakt dat onze supplementen veilig, en zonder ongewenste bijwerkingen, gebruikt kunnen worden. Onze producten zijn low FODMAP Certified™ door de Monash University.

Gratis advies van onze diëtisten

Gratis advies van onze diëtisten

Ons team van gespecialiseerde diëtisten staat altijd voor je klaar met praktisch advies en aanvullende informatie over onze producten. Neem contact met ons op via:

Chat: voor snel en direct advies
Mail: info@intoleran.com
Telefoon: +31302272172

Al meer dan 100.000 tevreden klanten

Al meer dan 100.000 tevreden klanten

Sinds 2008 is het onze missie om “iedereen van hun eten te laten genieten”. Wij zijn er trots op dat we al meer dan 100.000 klanten hebben kunnen ondersteunen.

Intoleran Nederland

Flag nl nl
0

Wetenschappelijke achtergrond

Literatuur enzymen

  1. Ahn SI, Kim MS, Park DG, Han BK, Kim YJ. Effects of probiotics administration on lactose intolerance in adulthood: a meta-analysis. J Dairy Sci. 2023;106(7):4489–501.
  2. Ahmed M, Billoo AG, Iqbal K, Memon A. Clinical efficacy of lactase enzyme supplement in infant colic: a randomised controlled trial. J Pak Med Assoc. 2018;68(12):1744–7.
  3. Baijal R, Tandon RK. Effect of lactase on symptoms and hydrogen breath levels in lactose intolerance: a crossover placebo-controlled study. JGH Open. 2021;5(1):143–8.
  4. Catanzaro R, Sciuto M, Marotta F. Lactose intolerance: an update on its pathogenesis, diagnosis, and treatment. Nutr Res. 2021;89:23–34.
  5. Fassio F, Facioni M, Guagnini F. Lactose maldigestion, malabsorption, and intolerance: a comprehensive review with a focus on current management and future perspectives. Nutrients. 2018;10(11):1599.
  6. Kanabar D, Randhawa M, Clayton P. Improvement of symptoms in infant colic following reduction of lactose load with lactase. J Hum Nutr Diet. 2001;14(5):359–63.
  7. Leis R, de Castro MJ, de Lamas C, Picáns R, Couce ML. Effects of prebiotic and probiotic supplementation on lactase deficiency and lactose intolerance: a systematic review of controlled trials. Nutrients. 2020;12(5).
  8. Montalto M, Nucera G, Santoro L, Curigliano V, Vastola M, Covino M, et al. Effect of exogenous beta-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study. Eur J Clin Nutr. 2005;59(4):489–93.
  9. Oak SJ, Jha R. The effects of probiotics in lactose intolerance: a systematic review. Crit Rev Food Sci Nutr. 2019;59(11):1675–83.
  10. Shah D, M. Oral lactase for infantile colic: a randomized double-blind placebo-controlled trial. BMC Pediatr. 2022;22(1):468.

  1. Benardout M, Gresley AL, ElShaer A, Wren SP. Fructose malabsorption: causes, diagnosis and treatment. Br J Nutr. 2022;127(4):481–9.
  2. Pongracz C, Pfisterer M, Missbichler A. Orally administered xylose isomerase converts fructose to glucose – a promising approach in case of fructose malabsorption. Clin Nutr Suppl. 2010;5(1):12–3.
  3. Shepherd SJ, Gibson PR. The complete low-FODMAP diet: the revolutionary plan for managing symptoms in IBS, Crohn’s disease, coeliac disease and other digestive disorders. London: Random House; 2014.

  1. Atzler JJ, Ispiryan L, Gallagher E, Sahin AW, Zannini E, Arendt EK. Enzymatic degradation of FODMAPs via application of β-fructofuranosidases and α-galactosidases- A fundamental study. J Cereal Sci. 2020;95:102993.
  2. Böhn L, Törnblom H, Van Oudenhove L, Simrén M, Störsrud S. A randomized double‐blind placebo‐controlled crossover pilot study: acute effects of the enzyme α‐galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients. Neurogastroenterol Motil. 2021;33(7).
  3. Di Nardo G, Oliva S, Ferrari F, Mallardo S, Barbara G, Cremon C, et al. Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial. BMC Gastroenterol. 2013;13(1).
  4. Di Stefano M, Miceli E, Gotti S, Missanelli A, Mazzocchi S, Corazza GR. The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms. Dig Dis Sci. 2007;52(1):78–83.
  5. Ganiats TG, Norcross WA, Halverson AL, Burford PA, Palinkas LA. Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract. 1994;39(5):441–5.
  6. Tuck CJ, Taylor KM, Gibson PR, Barrett JS, Muir JG. Increasing symptoms in irritable bowel symptoms with ingestion of galacto-oligosaccharides are mitigated by α-galactosidase treatment. Am J Gastroenterol. 2018;113(1):124–34.

  1. Duelo A, Sánchez-Pérez S, Ruiz-Leon AM, Casanovas-Garriga F, Pellicer-Roca S, Iduriaga-Platero I, et al. Study protocol for a prospective, unicentric, double-blind, randomized, and placebo-controlled trial on the efficacy of a low-histamine diet and DAO enzyme supplementation in patients with histamine intolerance. Nutrients. 2024;17(1):29.
  2. Jackson K, Busse W, Gálvez-Martín P, Terradillos A, Martínez-Puig D. Evidence for dietary management of histamine intolerance. Int J Mol Sci. 2025;26(18):9198.
  3. Jochum C. Histamine intolerance: symptoms, diagnosis, and beyond. Nutrients. 2024 Apr 19;16(8):1219–9.
  4. Komericki P, Klein G, Reider N, Hawranek T, Strimitzer T, Lang R, et al. Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: a randomised, double-blind, placebo-controlled cross-over study. Wien Klin Wochenschr. 2010 Dec 20;123(1-2):15–20.
  5. Schnedl WJ, Schenk M, Lackner S, et al. Diamine oxidase supplementation improves symptoms in patients with histamine intolerance. Food Sci Biotechnol. 2019;28:1779–84.

  1. Failla ML. Considerations for determining ‘optimal nutrition’ for copper, zinc, manganese and molybdenum. Proc Nutr Soc. 1999 May;58(2):497-505. doi: 10.1017/s0029665199000646. PMID: 10466195.
  2. Jafarinia M, Sadat Hosseini M, Kasiri N, Fazel N, Fathi F, Ganjalikhani Hakemi M, et al. Quercetin with the potential effect on allergic diseases. Allergy, Asthma & Clin Immunol. 2020 May 14;16(1).
  3. Johnston CS, Martin LJ, Cai X. Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis. J Am Coll Nutr. 1992 Apr 1;11(2):172–6.
  4. Jones AA, DiSilvestro RA, Coleman M, Wagner TL. Copper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease risk. Metabolism. 1997 Dec;46(12):1380–3.
  5. Jochum C. Histamine intolerance: symptoms, diagnosis, and beyond. Nutrients. 2024 Apr 19;16(8):1219–9.
  6. Kovacova-Hanuskova E, Buday T, Gavliakova S, Plevkova J. Histamine, histamine intoxication and intolerance. Allergol Immunopathol (Madr). 2015 Sep;43(5):498–506.
  7. Mlcek J, Jurikova T, Skrovankova S, Sochor J. Quercetin and its anti-allergic immune response. Molecules. 2016 May 12;21(5):623.
  8. San Mauro Martin I, Brachero S, Garicano Vilar E. Histamine intolerance and dietary management: a complete review. Allergol Immunopathol (Madr). 2016 Sep;44(5):475–83.
  9. Schnedl WJ, Schenk M, Lackner S, et al. Diamine oxidase supplementation improves symptoms in patients with histamine intolerance. Food Sci Biotechnol. 2019;28:1779–84.

  1. Danialifar TF, Chumpitazi BP, Mehta DI, Di Lorenzo C. Genetic and acquired sucrase-isomaltase deficiency: A clinical review. J Pediatr Gastroenterol Nutr. 2024 Apr;78(4):774–82.
  2. Frissora CL, Rao SSC. Sucrose intolerance in adults with common functional gastrointestinal symptoms. Proc (Bayl Univ Med Cent). 2022 Aug 23;35(6):790-793. doi: 10.1080/08998280.2022.2114070. PMID: 36304608; PMCID: PMC9586574.
  3. Layer P, Zinsmeister AR, DiMagno EP. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology. 1986 Jul;91(1):41–8. 
  4. Lebenthal E, None Khin-Maung-U, Zheng BY, Lu RB, Lerner A. Small intestinal glucoamylase deficiency and starch malabsorption: A newly recognized alpha-glucosidase deficiency in children. J Pediatr. 1994 Apr 1;124(4):541–6.
  5. Lin AH, Hamaker BR, Nichols BL. Direct starch digestion by Sucrase‐Isomaltase and Maltase‐Glucoamylase. J Pediatr Gastroenterol Nutr. 2012;55(S2).
  6. Lin AH, Nichols BL, Quezada-Calvillo R, Avery SE, Sim L, Rose DR, Naim HY, Hamaker BR. Unexpected high digestion rate of cooked starch by the CT-Maltase-Glucoamylase small intestine mucosal α-glucosidase subunit. PLoS ONE. 2012;7(5):e35473.
  7. Nichols BL, Avery SE, Quezada‐Calvillo R, Kilani SB, Lin AH, Burrin DG, Hodges BE, Chacko SK, Opekun AR, Hindawy ME, Hamaker BR, Oda S. Improved starch digestion of sucrase-deficient shrews treated with oral glucoamylase enzyme supplements. J Pediatr Gastroenterol Nutr. 2017;65(2).
  8. Ohlsson B. Theories behind the effect of starch and sucrose reduced diets on gastrointestinal symptoms in irritable bowel syndrome (Review). Mol Med Rep. 2021 Oct;24(4):732. doi: 10.3892/mmr.2021.12372. Epub 2021 Aug 20. PMID: 34414452; PMCID: PMC8404103.
  9. Robayo‐Torres CC, Opekun AR, Quezada‐Calvillo R, Villa X, Smith E, Navarrete M, Baker SS, Nichols BL. 13C‐Breath tests for sucrose digestion in congenital sucrase isomaltase–deficient and sacrosidase‐supplemented patients. J Pediatr Gastroenterol Nutr. 2009;48(4):412–418.
  10. Street K, Tao W, Cash B, Leung J, Hayes C, Cooper D, et al. The sucrose challenge symptoms test optimized for diagnosis of congenital sucrase isomaltase deficiency. PLoS ONE. 2024;19(9):e0310705.
  11. Treem WR, Ahsan N, Sullivan B, Rossi T, Holmes R, Fitzgerald J, Proujansky R, Hyams J. Evaluation of liquid yeast-derived sucrase enzyme replacement in patients with sucrase-isomaltase deficiency. Gastroenterology. 1993 Oct;105(4):1061-8. doi: 10.1016/0016-5085(93)90950-h. PMID: 8405850.
  12. Treem WR, McAdams L, Stanford L, Kastoff G, Justinich C, Hyams J. Sacrosidase therapy for congenital sucrase-isomaltase deficiency. J Pediatr Gastroenterol Nutr. 1999 Feb;28(2):137-42. doi: 10.1097/00005176-199902000-00008. PMID: 9932843.
  13. Zhang B, Dhital S, Gidley MJ. Synergistic and antagonistic effects of α-Amylase and amyloglucosidase on starch digestion. Biomacromolecules. 2013 Jun 10;14(6):1945-54. doi: 10.1021/bm400332a. Epub 2013 May 22. PMID: 23647443.
  14. Zhang X, Xue F, Xu K, Liu Q, Guo G, Huo W, et al. Effects of α-amylase and coated α-amylase supplementation on growth performance, nutrient digestion, and rumen fermentation in Holstein bulls. Front Vet Sci. 2024 Jan 8;10.

  1. Paulussen KJM, Askow AT, Deutz MT, McKenna CF, Garvey SM, Guice JL, et al. Acute microbial protease supplementation increases net postprandial plasma amino acid concentrations after pea protein ingestion in healthy adults: a randomized, double-blind, placebo-controlled trial. J Nutr. 2024 Mar 1.
  2. Ullah H, Di Minno A, Piccinocchi R, Buccato DG, De Lellis LF, Baldi A, et al. Efficacy of digestive enzyme supplementation in functional dyspepsia: a monocentric, randomized, double-blind, placebo-controlled, clinical trial. Biomed Pharmacother. 2023 Dec 31;169:115858.

  1. Ianiro G, Pecere S, Giorgio V, Gasbarrini A, Cammarota G. Digestive enzyme supplementation in gastrointestinal diseases. Curr Drug Metab. 2016;17(2):187–93.
  2. Levine ME, Koch SY, Koch KL. Lipase supplementation before a high-fat meal reduces perceptions of fullness in healthy subjects. Gut Liver. 2015;9(4):464–9.
  3. Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency – Breaking the myths. BMC Med [Internet]. 2017;15(1):29. 
  4. Suarez F, Levitt MD, Adshead J, Barkin JS. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. Dig Dis Sci. 1999;44(7):1317–21.
  5. Swami OC, Shah NJ. Functional dyspepsia and the role of digestive enzymes supplement in its therapy. Int J Basic Clin Pharmacol [Internet]. 2017 [cited 2026 Jan 8];6(5):1035. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1483

Literatuur voorlichtingsmateriaal

  1. Gibb RD, Sloan KJ, McRorie JW Jr. Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: A comprehensive review and meta-analysis. J Am Assoc Nurse Pract. 2023 Aug 1;35(8):468-476. doi: 10.1097/JXX.0000000000000882. PMID: 37163454; PMCID: PMC10389520.
  2. McRorie, Johnson W. Jr PhD, FACG, AGAF, FACN; Gibb, Roger D. PhD; Sloan, Kyle J. PharmD; McKeown, Nicola M. PhD. Psyllium: The Gel-Forming Nonfermented Isolated Fiber That Delivers Multiple Fiber-Related Health Benefits. Nutrition Today 56(4):p 169-182, 7/8 2021. | DOI: 10.1097/NT.0000000000000489
  3. Garg, P.K. (2017). Psyllium Husk Should Be Taken at Higher Dose with Sufficient Water to Maximize Its Efficacy. Journal of the Academy of Nutrition and Dietetics, 117 5, 681
  4. Salguero Molpeceres O, Seijas Ruiz-Coello MC, Hernández Núñez J, Caballos Villar D, Díaz Picazo L, Ayerbe García-Monzón L. Obstrucción esofágica por la fibra dietética Plantago ovata, una complicación prevenible mediante la información [Esophageal obstruction caused by dietary fiber from Plantago ovata, a complication preventable by adequate information]. Gastroenterol Hepatol. 2003 Apr;26(4):248-50. Spanish. PMID: 12681118.
  5. Hefny AF, Ayad AZ, Matev N, Bashir MO. Intestinal obstruction caused by a laxative drug (Psyllium): A case report and review of the literature. Int J Surg Case Rep. 2018;52:59-62. doi: 10.1016/j.ijscr.2018.10.001. Epub 2018 Oct 8. PMID: 30321826; PMCID: PMC6197948
  6. Shah, Aunjum Reyaz MTech; Sharma, Paras PhD; Longvah, Thingnganing PhD; Gour, Vinod Singh PhD; Kothari, S. L.; Shah, Yasir Reyaz MTech; Ganie, Showkat Ahmad PhD. Nutritional Composition and Health Benefits of Psyllium (Plantago ovata) Husk and Seed. Nutrition Today 55(6):p 313-321, 11/12 2020. | DOI: 10.1097/NT.0000000000000450
  7. Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial, Shulman, Robert J. et al. Clinical Gastroenterology and Hepatology, Volume 15, Issue 5, 712 – 719.e4
  8. Stevens, J., Vansoest, P., Robertson, J., & Levitsky, D. (1988). Comparison of the effects of psyllium and wheat bran on gastrointestinal transit time and stool characteristics.. Journal of the American Dietetic Association, 88 3, 323-6 . https://doi.org/10.1016/s0002-8223(21)01971-4.
  9. Chiu, A., & Sherman, S. (1998). Effects of pharmacological fiber supplements on levothyroxine absorption.. Thyroid : official journal of the American Thyroid Association, 8 8, 667-71 . https://doi.org/10.1089/THY.1998.8.667.
  10. Roe, D., Kalkwarf, H., & Stevens, J. (1988). Effect of fiber supplements on the apparent absorption of pharmacological doses of riboflavin.. Journal of the American Dietetic Association, 88 2, 211-3 . https://doi.org/10.1016/s0002-8223(21)01943-x.
  11. Hołownia, P., Jaworska-Luczak, B., Wiśniewska, I., Biliński, P., & Wojtyła, A. (2010). The benefits & potential health hazards posed by the prebiotic inulin – a review. Polish Journal of Food and Nutrition Sciences, 60, 201-211.
  12. Teferra, T. F. (2021). Possible actions of inulin as prebiotic polysaccharide: A review. Food Frontiers. doi:10.1002/fft2.92
  13. Micka, A., Siepelmeyer, A., Holz, A., Theis, S., & Schön, C. (2016). Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial. International Journal of Food Sciences and Nutrition, 68(1), 82–89. https://doi.org/10.1080/09637486.2016.1212819
  14. Watson AW, Houghton D, Avery PJ, Stewart C, Vaughan EE, Meyer PD, de Bos Kuil MJJ, Weijs PJM, Brandt K. Changes in stool frequency following chicory inulin consumption, and effects on stool consistency, quality of life and composition of gut microbiota. Food Hydrocoll. 2019 Nov;96:688-698. doi: 10.1016/j.foodhyd.2019.06.006. PMID: 31680713; PMCID: PMC6686634.
  15. Momo Cabrera P, Rachmühl C, Derrien M, Bourdet-Sicard R, Lacroix C, Geirnaert A. Comparative prebiotic potential of galacto- and fructo-oligosaccharides, native inulin, and acacia gum in Kenyan infant gut microbiota during iron supplementation. ISME Commun. 2024 Mar 11;4(1):ycae033. doi: 10.1093/ismeco/ycae033. PMID: 38774131; PMCID: PMC11107946.
  16. Cherbut, C., Michel, C., Raison, V., Kravtchenko, T., & Severine, M. (2003). Acacia Gum is a Bifidogenic Dietary Fibre with High Digestive Tolerance in Healthy Humans. Microbial Ecology in Health and Disease, 15, 43 – 50. https://doi.org/10.1080/08910600310014377.
  17. Barber C, Sabater C, Guarner F, Margolles A, Azpiroz F. Metabolic response of intestinal microbiota to guar gum consumption. Front Nutr. 2023 Jun 30;10:1160694. doi: 10.3389/fnut.2023.1160694. PMID: 37457982; PMCID: PMC10349393.
  18. Hartemink, R., Schoustra, S., & Rombouts, F. (1999). Degradation of guar gum by intestinal bacteria. Bioscience and microflora, 18, 17-25. https://doi.org/10.12938/BIFIDUS1996.18.17.
  19. Todd, P., Benfield, P., & Goa, K. (1990). Guar gum. A review of its pharmacological properties, and use as a dietary adjunct in hypercholesterolaemia.. Drugs, 39 6, 917-28.
  20. Theertham Pradyumna Rao, Giuseppina Quartarone, Role of guar fiber in improving digestive health and function, Nutrition, Volume 59, 2019, Pages 158-169, ISSN 0899-9007, https://doi.org/10.1016/j.nut.2018.07.109.
  21. Slavin JL, Greenberg NA. Partially hydrolyzed guar gum: clinical nutrition uses. Nutrition. 2003 Jun;19(6):549-52. doi: 10.1016/s0899-9007(02)01032-8. PMID: 12781858.
  22. Tsutomu Okubo, Noriyuki Ishihara, Hidehisa Takahashi, Tomohiko Fujisawa, Mujo Kim, Takehiko Yamamoto, Tomotari Mitsuoka, Effects of Partially Hydrolyzed Guar Gum Intake on Human Intestinal Microflora and Its Metabolism, Bioscience, Biotechnology, and Biochemistry, Volume 58, Issue 8, 1 January 1994, Pages 1364–1369, https://doi.org/10.1271/bbb.58.1364
  23. Maeda H, et al. | Partially hydrolyzed guar gum intake ameliorates constipation, improves nutritional status and reduces indoxylsulfuric acid in dialysis patients. Kidney Res Clin Practice 2012; 31: A53 (Reference 133).
  24. Patrick PG, Gohman SM, Marx SC, DeLegge MH, Greenberg NA. Effect of supplements of partially hydrolyzed guar gum on the occurrence of constipation and use of laxative agents. J Am Diet Assoc. 1998 Aug;98(8):912-4. doi: 10.1016/S0002-8223(98)00210-7. PMID: 9710664.
  25. Giaccari S, Grasso G, Tronci S, Allegretta L, Sponziello G, Montefusco A, Siciliano IG, Guarisco R, Candiani C, Chiri S. Gomma guar parzialmente idrolizzata: una fibra come coadiuvante nella sindrome del colon irritabile [Partially hydrolyzed guar gum: a fiber as coadjuvant in the irritable colon syndrome]. Clin Ter. 2001 Jan-Feb;152(1):21-5. Italian. PMID: 11382164.
  26. Paesani, C., Salvucci, E., Moiraghi, M., Canigia, F., & Pérez, G. (2019). Arabinoxylan from Argentinian whole wheat flour promote the growth of Lactobacillus reuteri and Bifidobacterium breve. Letters in Applied Microbiology, 68. https://doi.org/10.1111/lam.13097.
  27. Arffmann, S., Andersen, J. R., Hegnhøj, J., Schaffalitzky De Muckadell, O. B., Mogensen, N. B., & Krag, E. (1985). The Effect of Coarse Wheat Bran in the Irritable Bowel Syndrome lA Double-Blind Cross-Over Study. Scandinavian Journal of Gastroenterology, 20(3), 295–298. https://doi.org/10.3109/00365528509091653
  28. Lewis MJ, Whorwell PJ. Bran: may irritate irritable bowel. Nutrition. 1998 May;14(5):470-1. doi: 10.1016/s0899-9007(97)00498-x. PMID: 9614316.
  29. Puhlmann M-L, Jokela R, van Dongen KCW, et al. Dried chicory root improves bowel function, benefits intestinal microbial trophic chains and increases faecal and circulating short chain fatty acids in subjects at risk for type 2 diabetes. Gut Microbiome. 2022;3:e4. doi:10.1017/gmb.2022.4
  30. Carlson, J., Erickson, J., Hess, J., Gould, T., & Slavin, J. (2017). Prebiotic Dietary Fiber and Gut Health: Comparing the in Vitro Fermentations of Beta-Glucan, Inulin and Xylooligosaccharide. Nutrients, 9. https://doi.org/10.3390/nu9121361.
  31. Connolly, M., Lovegrove, J., & Tuohy, K. (2010). Konjac glucomannan hydrolysate beneficially modulates bacterial composition and activity within the faecal microbiota. Journal of Functional Foods, 2, 219-224. https://doi.org/10.1016/J.JFF.2010.05.001.
  32. Marsicano LJ, Berrizbeitia ML, Mondelo A. Uso de la fibra dietética de glucomannan en la modificación del hábito intestinal [Use of glucomannan dietary fiber in changes in intestinal habit]. G E N. 1995 Jan-Mar;49(1):7-14. Spanish. PMID: 8566676.
  33. Staiano A, Simeone D, Del Giudice E, Miele E, Tozzi A, Toraldo C. Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children. J Pediatr. 2000 Jan;136(1):41-5. doi: 10.1016/s0022-3476(00)90047-7. PMID: 10636972.
  34. Loening-Baucke V, Miele E, Staiano A. Fiber (glucomannan) is beneficial in the treatment of childhood constipation. Pediatrics. 2004 Mar;113(3 Pt 1):e259-64. doi: 10.1542/peds.113.3.e259. PMID: 14993586.
  35. Han Y, Zhang L, Liu XQ, Zhao ZJ, Lv LX. Effect of glucomannan on functional constipation in children: a systematic review and meta-analysis of randomised controlled trials. Asia Pac J Clin Nutr. 2017 May;26(3):471-477. doi: 10.6133/apjcn.032016.03. PMID: 28429913.

  1. Cheng J, Laitila A, Ouwehand AC. Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review. Front Nutr. 2021 Dec 14;8:790561. doi: 10.3389/fnut.2021.790561. PMID: 34970580; PMCID: PMC8712437. 
  1. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018;9(3):236-251. doi: 10.1080/19490976.2017.1412908. Epub 2018 Feb 8. PMID: 29227175; PMCID: PMC6219592. 
  1. Mogna L, Del Piano M, Mogna G. Capability of the two microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to colonize the intestinal microbiota of children. J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S37-9. doi: 10.1097/MCG.0000000000000234. PMID: 25291125. 
  1. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S104-6. doi: 10.1097/01.mcg.0000129271.98814.e2. Erratum in: J Clin Gastroenterol. 2005 Mar;39(3):261. PMID: 15220671. 
  1. Madempudi, R.S., Ahire, J.J., Neelamraju, J. et al. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep 9, 12210 (2019). https://doi.org/10.1038/s41598-019-48554-x 
  1. Rogha M, Esfahani MZ, Zargarzadeh AH. The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench. 2014 Summer;7(3):156-63. PMID: 25120896; PMCID: PMC4129566. 
  1. Sudha, M. R., Jayanthi, N., Aasin, M., Dhanashri, R.D., & Anirudh, T. (2018). Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study. Beneficial Microbes, 9(4), 563-572. https://doi.org/10.3920/BM2017.0129 
  1. Bonavina L, Arini A, Ficano L, Iannuzziello D, Pasquale L, Aragona SE, Ciprandi G, On Digestive Disorders ISG. Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders. Acta Biomed. 2019 Jul 10;90(7-S):8-12. doi: 10.23750/abm.v90i7-S.8649. PMID: 31292420; PMCID: PMC6776171. 
  1. Bonavina L, Ariani A, Ficano L, Iannuzziello D, Pasquale L, Aragona SE, Drago L, Ciprandi G, On Digestive Disorders ISG. Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation. Acta Biomed. 2019 Jul 10;90(7-S):13-17. doi: 10.23750/abm.v90i7-S.8650. PMID: 31292421; PMCID: PMC6776169. 
  1. Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol. 2011 Jul;45(6):518-25. doi: 10.1097/MCG.0b013e31820ca4d6. PMID: 21436726; PMCID: PMC4372813. 
  1. Sadrin S, Sennoune SR, Gout B, Marque S, Moreau J, Grillasca J, Pons O, Maixent JM. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial. Cell Mol Biol (Noisy-le-grand). 2017 Sep 30;63(9):122-131. doi: 10.14715/cmb/2017.63.9.21. PMID: 28980935. 
  1. Wu KL, Rayner CK, Chuah SK, Changchien CS, Lu SN, Chiu YC, Chiu KW, Lee CM. Effects of ginger on gastric emptying and motility in healthy humans. Eur J Gastroenterol Hepatol. 2008 May;20(5):436-40. doi: 10.1097/MEG.0b013e3282f4b224. PMID: 18403946. 
  1. Karampour, N., Arzi, A., Rezaie, A., Pashmforoosh, M., & Kordi, F. (2019). Gastroprotective Effect of Zingerone on Ethanol-Induced Gastric Ulcers in Rats. Medicina, 55. https://doi.org/10.3390/medicina55030064. 
  1. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008 Feb;46(2):409-20. doi: 10.1016/j.fct.2007.09.085. Epub 2007 Sep 18. PMID: 17950516. 
  1. Lashgari, N., Roudsari, N., Khayatan, D., Shayan, M., Momtaz, S., Roufogalis, B., Abdolghaffari, A., & Sahebkar, A. (2021). Ginger and its constituents: Role in treatment of inflammatory bowel disease. BioFactors, 48, 21 – 7. https://doi.org/10.1002/biof.1808. 
  1. Terry R, Posadzki P, Watson LK, Ernst E. The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med. 2011 Dec;12(12):1808-18. doi: 10.1111/j.1526-4637.2011.01261.x. Epub 2011 Nov 4. PMID: 22054010. 
  1. Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome. Gastroenterology. 2020 Jan;158(1):123-136. doi: 10.1053/j.gastro.2019.08.026. Epub 2019 Aug 27. PMID: 31470006. 
  1. Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis. 2007 Jun;39(6):530-6. doi: 10.1016/j.dld.2007.02.006. Epub 2007 Apr 8. PMID: 17420159 
  1. Pittler, M., & Ernst, E. (1998). Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. American Journal of Gastroenterology, 93, 1131-1135. https://doi.org/10.1111/j.1572-0241.1998.00343.x. 
  1. Weerts, Z., Masclee, A., Witteman, B., Clemens, C., Winkens, B., Brouwers, J., Frijlink, H., Muris, J., Wit, N., Essers, B., Tack, J., Snijkers, J., Bours, A., Ploeg, A., Jonkers, D., & Keszthelyi, D. (2019). Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome.. Gastroenterology. https://doi.org/10.1053/j.gastro.2019.08.026. 
  1. Kline, R., Kline, J., Palma, J., & Barbero, G. (2001). Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.. The Journal of pediatrics, 138 1, 125-8 . https://doi.org/10.1067/MPD.2001.109606. 
  1. Platel, K., & Srinivasan, K. (2000). Stimulatory influence of select spices on bile secretion in rats.. Nutrition Research, 20, 1493-1503. https://doi.org/10.1016/S0271-5317(00)80030-5. 
  1. Kalpana, P., & Srinivasan, K. (2001). A study of the digestive stimulant action of select spices in experimental rats.. Journal of Food Science and Technology-mysore, 38, 358-361. 
  1. Sahoo, S., & Brijesh, S. (2020). Anxiolytic activity of Coriandrum sativum seeds aqueous extract on chronic restraint stressed mice and effect on brain neurotransmitters. Journal of Functional Foods, 68, 103884. https://doi.org/10.1016/j.jff.2020.103884. 
  1. Jabeen, Q., Bashir, S., Lyoussi, B., & Gilani, A. (2009). Coriander fruit exhibits gut modulatory, blood pressure lowering and diuretic activities.. Journal of ethnopharmacology, 122 1, 123-30 . https://doi.org/10.1016/j.jep.2008.12.016. 
  1. Heidari, B., Sajjadi, S., & Minaiyan, M. (2016). Effect of Coriandrum sativum hydroalcoholic extract and its essential oil on acetic acid- induced acute colitis in rats. Avicenna Journal of Phytomedicine, 6, 205 – 214. https://doi.org/10.22038/AJP.2016.5157. 
  1. Achamrah, N., Déchelotte, P., & Coëffier, M. (2017). Glutamine and the regulation of intestinal permeability: from bench to bedside. Current Opinion in Clinical Nutrition and Metabolic Care, 20, 86–91. https://doi.org/10.1097/MCO.0000000000000339. 
  1. Bertrand, J., Ghouzali, I., Guérin, C., Bole-Feysot, C., Gouteux, M., Déchelotte, P., Ducrotte, P., & Coëffier, M. (2016). Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.. JPEN. Journal of parenteral and enteral nutrition, 40 8, 1170-1176 . https://doi.org/10.1177/0148607115587330. 
  1. Rastgoo, S., Ebrahimi‐Daryani, N., Agah, S., Karimi, S., Taher, M., Rashidkhani, B., Hejazi, E., Mohseni, F., Ahmadzadeh, M., Sadeghi, A., & Hekmatdoost, A. (2021). Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management. Frontiers in Nutrition, 8. https://doi.org/10.3389/fnut.2021.746703.  

  1. Giannini EG, Mansi C, Dulbecco P, Savarino V. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition. 2006 Mar;22(3):334-42. doi: 10.1016/j.nut.2005.10.003. Epub 2006 Jan 18. PMID: 16413751.
  2. Romano C, Comito D, Famiani A, Calamarà S, Loddo I. Partially hydrolyzed guar gum in pediatric functional abdominal pain. World J Gastroenterol. 2013 Jan 14;19(2):235-40. doi: 10.3748/wjg.v19.i2.235. PMID: 23345946; PMCID: PMC3547554.
  3. Parisi GC, Zilli M, Miani MP, Carrara M, Bottona E, Verdianelli G, Battaglia G, Desideri S, Faedo A, Marzolino C, Tonon A, Ermani M, Leandro G. High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). Dig Dis Sci. 2002 Aug;47(8):1697-704. doi: 10.1023/a:1016419906546. PMID: 12184518.
  4. Mahendra P. Kapoor, Masaaki Sugita, Yoshitaka Fukuzawa, Tsutomu Okubo, Impact of partially hydrolyzed guar gum (PHGG) on constipation prevention: A systematic review and meta-analysis, Journal of Functional Foods, Volume 33, 2017, Pages 52-66, ISSN 1756-4646, https://doi.org/10.1016/j.jff.2017.03.028.
  5. Elizabeth Steels, Rene Erhardt, Joanna E. Harnett, Vanessa Vigar, Kathryn J. Steadman, Efficacy of a prebiotic formulation for treatment of functional constipation and associated gastrointestinal symptoms in adults: A randomised controlled trial, Advances in Integrative Medicine, Volume 10, Issue 2, 2023, Pages 43-50, ISSN 2212-9588, https://doi.org/10.1016/j.aimed.2023.05.001.
  6. Polymeros D, Beintaris I, Gaglia A, Karamanolis G, Papanikolaou IS, Dimitriadis G, Triantafyllou K. Partially hydrolyzed guar gum accelerates colonic transit time and improves symptoms in adults with chronic constipation. Dig Dis Sci. 2014 Sep;59(9):2207-14. doi: 10.1007/s10620-014-3135-1. Epub 2014 Apr 8. PMID: 24711073.
  7. Inoue R, Sakaue Y, Kawada Y, Tamaki R, Yasukawa Z, Ozeki M, Ueba S, Sawai C, Nonomura K, Tsukahara T, Naito Y. Dietary supplementation with partially hydrolyzed guar gum helps improve constipation and gut dysbiosis symptoms and behavioral irritability in children with autism spectrum disorder. J Clin Biochem Nutr. 2019 May;64(3):217-223. doi: 10.3164/jcbn.18-105. Epub 2019 Mar 7. PMID: 31138955; PMCID: PMC6529696.
  8. Yasukawa Z, Inoue R, Ozeki M, Okubo T, Takagi T, Honda A, Naito Y. Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial. Nutrients. 2019 Sep 10;11(9):2170. doi: 10.3390/nu11092170. PMID: 31509971; PMCID: PMC6769658.
  9. Rosli, D., Shahar, S., Manaf, Z., Lau, H., Yusof, N., Haron, M., & Majid, H. (2020). A Randomised Controlled Trial on the Effect of Partially Hydrolyzed Guar Gum (PHGG) Supplementation on DAiarrhea Frequency and Gut Microbiome Count Among Pelvic Radiation Patients.. JPEN. Journal of parenteral and enteral nutrition. https://doi.org/10.1002/jpen.1987.
  10. Nakamura S, Hongo R, Moji K, Oku T. Suppressive effect of partially hydrolyzed guar gum on transitory diarrhea induced by ingestion of maltitol and lactitol in healthy humans. Eur J Clin Nutr. 2007 Sep;61(9):1086-93. doi: 10.1038/sj.ejcn.1602623. Epub 2007 Jan 24. PMID: 17251924.
  11. Tsutomu Okubo, Noriyuki Ishihara, Hidehisa Takahashi, Tomohiko Fujisawa, Mujo Kim, Takehiko Yamamoto, Tomotari Mitsuoka, Effects of Partially Hydrolyzed Guar Gum Intake on Human Intestinal Microflora and Its Metabolism, Bioscience, Biotechnology, and Biochemistry, Volume 58, Issue 8, 1 January 1994, Pages 1364–1369, https://doi.org/10.1271/bbb.58.1364
  12. Ohashi Y, Sumitani K, Tokunaga M, Ishihara N, Okubo T, Fujisawa T. Consumption of partially hydrolysed guar gum stimulates Bifidobacteria and butyrate-producing bacteria in the human large intestine. Benef Microbes. 2015;6(4):451-5. doi: 10.3920/BM2014.0118. Epub 2015 Feb 12. PMID: 25519526.
  13. Pylkas AM, Juneja LR, Slavin JL. Comparison of different fibers for in vitro production of short chain fatty acids by intestinal microflora. J Med Food. 2005 Spring;8(1):113-6. doi: 10.1089/jmf.2005.8.113. PMID: 15857221.
  14. Reider SJ, Moosmang S, Tragust J, Trgovec-Greif L, Tragust S, Perschy L, Przysiecki N, Sturm S, Tilg H, Stuppner H, Rattei T, Moschen AR. Prebiotic Effects of Partially Hydrolyzed Guar Gum on the Composition and Function of the Human Microbiota-Results from the PAGODA Trial. Nutrients. 2020 Apr 28;12(5):1257. doi: 10.3390/nu12051257. PMID: 32354152; PMCID: PMC7281958.
  15. Mahendra P. Kapoor, Masaaki Koido, Mikiko Kawaguchi, Derek Timm, Makoto Ozeki, Mari Yamada, Takayuki Mitsuya, Tsutomu Okubo, Lifestyle related changes with partially hydrolyzed guar gum dietary fiber in healthy athlete individuals – A randomized, double-blind, crossover, placebo-controlled gut microbiome clinical study, Journal of Functional Foods, Volume 72, 2020, 104067, ISSN 1756-4646, https://doi.org/10.1016/j.jff.2020.104067.
  16. Wu KL, Rayner CK, Chuah SK, Changchien CS, Lu SN, Chiu YC, Chiu KW, Lee CM. Effects of ginger on gastric emptying and motility in healthy humans. Eur J Gastroenterol Hepatol. 2008 May;20(5):436-40. doi: 10.1097/MEG.0b013e3282f4b224. PMID: 18403946.
  17. Karampour, N., Arzi, A., Rezaie, A., Pashmforoosh, M., & Kordi, F. (2019). Gastroprotective Effect of Zingerone on Ethanol-Induced Gastric Ulcers in Rats. Medicina, 55. https://doi.org/10.3390/medicina55030064.
  18. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008 Feb;46(2):409-20. doi: 10.1016/j.fct.2007.09.085. Epub 2007 Sep 18. PMID: 17950516
  19. Lashgari, N., Roudsari, N., Khayatan, D., Shayan, M., Momtaz, S., Roufogalis, B., Abdolghaffari, A., & Sahebkar, A. (2021). Ginger and its constituents: Role in treatment of inflammatory bowel disease. BioFactors, 48, 21 – 7. https://doi.org/10.1002/biof.1808.
  20. Terry R, Posadzki P, Watson LK, Ernst E. The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med. 2011 Dec;12(12):1808-18. doi: 10.1111/j.1526-4637.2011.01261.x. Epub 2011 Nov 4. PMID: 22054010.

  1. Veraza, D. I., et al. (2024). Diet and nutrient intake in adults with IBS: A systematic review and meta-analysis.
  2. Staudacher, H. M., et al. (2020). Nutrient intake and diet quality in IBS and the impact of a low-FODMAP diet.
  3. Molina-Infante, J., et al. (2016). The low-FODMAP diet for IBS: Lights and shadows.
  4. Schütte, O., et al. (2022). Pro-inflammatory diet in children with atopic dermatitis or food allergy.
  5. Abdi, F., et al. (2023). Nutritional considerations in coeliac disease and non-coeliac gluten/wheat sensitivity.
  6. Niv, E., et al. (2016). PHGG versus placebo in the treatment of IBS.
  7. Sakai, C., et al. (2019). Repeated PHGG intake: Effects on stool and microbiota.
  8. Monash University. (n.d.). Sunfiber®—Low FODMAP Certified™ ingredient.
  9. Taiyo International. (2025, maart). Sunfiber® partially hydrolyzed guar gum: Ingredient specification sheet.
  10. Clinical Nutrition ESPEN. (2023). Dietary management of constipation in Parkinson’s disease: A literature review.
  11. Tappenden, K. A., Driscoll, S. M., & Crowell, M. D. (2022). Observed dietary intake in adults with intellectual disability living in the community.
  12. Papanikolaou, I. S., et al. (2020). Prevalence of constipation and laxative use in elderly people: A systematic review.
  13. Polymeros, D., et al. (2020). The impact of dietary fibre intake on gastrointestinal symptoms and constipation in older adults.
  14. Steels, E., et al. (2023). Dietary fibre intake in the elderly population and its impact on gastrointestinal health.
  15. Inoue, R., et al. (2019). PHGG improves constipation and gut dysbiosis in children with autism spectrum disorder.
  16. Efficacy of a prebiotic formulation for treatment of functional constipation. Advances in Integrative Medicine (2023).
  17. Kapoor, M. P., et al. (2017). Impact of PHGG on constipation prevention: A systematic review and meta-analysis.
  18. Polymeros, D., et al. (2014). PHGG accelerates colonic transit time and improves symptoms in adults with chronic constipation.
  19. Minor, G., et al. (2023). Tolerability and safety of a semi-elemental formula with PHGG in tube-fed children.
  20. Veluvali, A., & Snyder, M. (2023). Dietary fibre deficiency in metabolic syndrome: A review.
  21. Slavin, J. L., & Lloyd, B. (2022). Impact of dietary fibre on insulin resistance and type 2 diabetes risk.
  22. Veluvali, A., & Snyder, M. (2023). Dietary fibre and cardiovascular risk in chronic kidney disease.
  23. Khan, S., et al. (2021). Prevalence of constipation in CKD patients on haemodialysis and peritoneal dialysis.
  24. Kranz, S., et al. (2012). What do we know about dietary fibre intake in children and health?
  25. Perrar, I., et al. (2024). DONALD cohort profile update.
  26. Roma, E., et al. (1999). Diet and chronic constipation in children: The role of fibre.
  27. Morais, M. B., et al. (1999). Low dietary fibre intake as a risk factor for chronic constipation in children.
  28. Salari, N., et al. (2024). Global prevalence of constipation during pregnancy: A meta-analysis.
  29. UZ Leuven. (z.d.). Constipatie en verstopping tijdens de zwangerschap.
  30. Üstündağ, G., et al. (2010). PHGG versus lactulose in childhood constipation.
  31. Romano, C., et al. (2013). PHGG in paediatric functional abdominal pain.
  32. Yoon, S.-J., Chu, D.-C., & Juneja, L. R. (2006). Physiological functions of PHGG.
  33. Life Sciences Research Office. (1993). Health aspects of using PHGG as a food ingredient.
  34. Luccia, B., & Kunkel, M. E. (2002). Psyllium reduces calcium bioavailability in rats.
  35. Asvarujanon, P., Ishizuka, S., & Hara, H. (2004). Viscosity-reduced psyllium and mineral absorption.
  36. Ribichini, E., et al. (2023). Exercise-induced GI symptoms in endurance sports.
  37. Moss, K., et al. (2023). Nutrient adequacy in endurance athletes.
  38. de Oliveira, E. P. (2013). Nutritional recommendations to avoid GI distress during exercise.
  39. Kapoor, M. P., et al. (2020). PHGG and gut microbiome in healthy athletes.
  40. Lu, C.-S., et al. (2021). The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson’s Disease: A Pilot Study.
Het product is toegevoegd aan uw winkelwagen Bekijk winkelwagen →
Sluit